how to administer tirzepatide injection Shots Want to learn more about

What to eat on GLP-1 or weight loss medication

Expert UK guidance on managing heavy menstrual bleeding during diabetes treatment.

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

According to the International Diabetes Federation[1], every year over 589 million adults worldwide grapple with diabetes, a number projected to soar past 850 million by 2050, making diabetes and obesity among the most urgent global health crises of our time

Stay informed and make empowered decisions!